Selective intraarterial radionuclide therapy with Yttrium-90 (Y-90) microspheres for unresectable primary and metastatic liver tumors

Selective intraarterial radionuclide therapy with Yttrium-90 (Y-90) microspheres for unresectable primary and metastatic liver tumors

Show other versions (1)

Bibliographic Details
Main Authors:	Ozkan Elgin, Lacin Seda, Soydal Cigdem, Kucuk N Ozlem, Bilgic Sadık
Format:	Article
Language:	English
Published:	BMC 2011-10-01
Series:	World Journal of Surgical Oncology
Online Access:	http://www.wjso.com/content/9/1/120

Similar Items

Selective intraarterial radionuclide therapy with Yttrium-90 (Y-90) microspheres for unresectable primary and metastatic liver tumors
by: Ozkan Elgin, et al.
Published: (2011-08-01)

Selective intraarterial radionuclide therapy with yttrium-90 (Y-90) microspheres for hepatic neuroendocrine metastases: Initial experience at a single center
by: Arslan Nuri, et al.
Published: (2011-01-01)

Yttrium-90 resin microspheres as an adjunct to sorafenib in patients with unresectable hepatocellular carcinoma
by: Mahvash A, et al.
Published: (2016-02-01)

A pooled analysis of transarterial radioembolization with yttrium-90 microspheres for the treatment of unresectable intrahepatic cholangiocarcinoma
by: Zhen Y, et al.
Published: (2019-06-01)

Yttrium-90 microsphere induced gastrointestinal tract ulceration
by: Rikabi Ali A, et al.
Published: (2008-09-01)

Assessment of radiation sensitivity of unresectable intrahepatic cholangiocarcinoma in a series of patients submitted to radioembolization with yttrium-90 resin microspheres
by: Tommaso Depalo, et al.
Published: (2021-10-01)

Outcomes and predictors of toxicity after selective internal radiation therapy using yttrium-90 resin microspheres for unresectable hepatocellular carcinoma
by: Andrew eGabrielson, et al.
Published: (2015-12-01)

Comparison of PET/CT and PET/MR imaging and dosimetry of yttrium-90 (90Y) in patients with unresectable hepatic tumors who have received intra-arterial radioembolization therapy with 90Y microspheres
by: Karin Knešaurek, et al.
Published: (2018-08-01)

Successful Yttrium-90 Microsphere Radioembolization for Hepatic Metastases of Prostate Cancer
by: Alexander C. Bunck, et al.
Published: (2017-07-01)

Yttrium-90 Microsphere Radioembolization for Treatment of Lung Cancer Hepatic Metastases
by: Ron C. Gaba, et al.
Published: (2012-08-01)

Yttrium-90 radioembolization of unresectable hepatocellular carcinoma – a single center experience
by: Meyer C, et al.
Published: (2017-09-01)

Yttrium-90 radioembolization for the treatment of unresectable liver cancer: Results of a single center
by: Özhan Özgür, et al.
Published: (2014-03-01)

Advances in SPECT for Optimizing the Liver Tumors Radioembolization Using Yttrium-90 Microspheres
by: Hoda Rezaei Roshan, et al.
Published: (2015-01-01)

The development, commercialization, and clinical context of yttrium-90 radiolabeled resin and glass microspheres
by: Mark A. Westcott, MD, et al.
Published: (2016-10-01)

Survival Outcomes for Yttrium-90 Transarterial Radioembolization With and Without Sorafenib for Unresectable Hepatocellular Carcinoma Patients
by: Teyateeti A, et al.
Published: (2020-09-01)

Efficacy and safety of selective internal radiation therapy with yttrium-90 for the treatment of unresectable hepatocellular carcinoma
by: Nguyen Van Thai, et al.
Published: (2021-05-01)

Trans-arterial 90yttrium radioembolization for patients with unresectable tumors originating from the biliary tree
by: Joost W. Wijlemans, et al.
Published: (2011-07-01)

Cholecystitis after yttrium-90 resin microsphere radioembolization treatment: Clinical and pathologic findings
by: Sagun Parakh, et al.
Published: (2016-07-01)

Theranostic Imaging of Yttrium-90
by: Chadwick L. Wright, et al.
Published: (2015-01-01)

Phosphorous-32 and Yttrium-90 as options in the treatment of metastatic bone pain
by: Alejandro Alberti Ramírez, et al.
Published: (2016-07-01)

90Y glass microspheres radionuclide therapy: robustness analysis with a dosimetry software
by: Forbes Aurélie, et al.
Published: (2019-01-01)

Monte Carlo modeling of the Yttrium-90 nanospheres application in the liver radionuclide therapy and organs doses calculation
by: Ghavami Seyed Mostafa, et al.
Published: (2016-01-01)

Side Effects of Yttrium-90 Radioembolization
by: Ahsun eRiaz, et al.
Published: (2014-07-01)

Clinical and laboratory toxicity after intra-arterial radioembolization with (90)y-microspheres for unresectable liver metastases.
by: Maarten L J Smits, et al.
Published: (2013-01-01)

Prediction of survival according to kinetic changes of cytokines and hepatitis status following radioembolization with yttrium-90 microspheres
by: Chien-An Liu, et al.
Published: (2021-04-01)

Ytrium 90 as a radionuclide for therapy
by: Alejandro Alberti Ramírez
Published: (2012-07-01)

Correction: Clinical and Laboratory Toxicity after Intra-Arterial Radioembolization with 90Y-Microspheres for Unresectable Liver Metastases
by: Maarten L. J. Smits, et al.
Published: (2013-01-01)

Quantitative comparison of PET and Bremsstrahlung SPECT for imaging the in vivo yttrium-90 microsphere distribution after liver radioembolization.
by: Mattijs Elschot, et al.
Published: (2013-01-01)

Radiation segmentectomy for hepatic malignancies: Indications, devices, dosimetry, procedure, clinical outcomes, and toxicity of yttrium-90 microspheres
by: Zhongzhi Jia, et al.
Published: (2019-02-01)

The effect of selective internal radiation therapy with yttrium-90 resin microspheres on lung carbon monoxide diffusion capacity
by: Tunc Ones, et al.
Published: (2017-12-01)

Transarterial radioembolization using yttrium-90 microspheres in the treatment of hepatocellular carcinoma: a review on clinical utility and developments
by: Cappelli A, et al.
Published: (2014-11-01)

Y-90 microshperes in the treatment of unresectable hepatocellular carcinoma
by: Al-Kalbani Abdullah, et al.
Published: (2008-01-01)

Imaging patterns of hepatocellular carcinoma and response to Yttrium 90
by: Ana Judite Martins dos Santos Pinto da Silva
Published: (2019)

Yttrium-90 radioembolization for advanced inoperable hepatocellular carcinoma
by: Lee VHF, et al.
Published: (2015-11-01)

History and Evolution of Yttrium-90 Radioembolization for Hepatocellular Carcinoma
by: Aman Saini, et al.
Published: (2019-01-01)

Experience of Yttrium-90 radioembolization in patients with hepatocellular carcinoma
by: B. Zapote Hernández, et al.
Published: (2020-09-01)

The role of 18F-FDG-PET/CT in the preoperative staging and posttherapy follow up of gastriccancer:Comparison with spiral CT
by: Soydal Cigdem, et al.
Published: (2011-07-01)

Lobar Hepatocellular Carcinoma with Ipsilateral Portal Vein Tumor Thrombosis Treated with Yttrium-90 Glass Microsphere Radioembolization: Preliminary Results
by: M. Pracht, et al.
Published: (2013-01-01)

Yttrium-90-Induced Gastropathy: A Potential Equivocal Finding
by: Rui Castro, et al.
Published: (2020-04-01)

Quantitative and qualitative assessment of Yttrium-90 PET/CT imaging.
by: Ali Asgar Attarwala, et al.
Published: (2014-01-01)